TGF-β signaling and the fibrotic response
The DOI matches its Crossref record; 152 of the 153 references it cites were found in a registry or an index.
Abstract
The cause of fibrotic diseases, pathologies characterized by excessive production, deposition, and contraction of extracellular matrix, is unknown. To understand the molecular basis of fibrotic disease, it is essential to appreciate how matrix deposition is normally controlled and how this process is dysregulated in fibrogenesis. This review discusses the current state of knowledge concerning interactions among the profibrotic proteins transforming growth factor‐β (TGF‐β), connective tissue growth factor (CTGF, CCN2), and ED‐A fibronectin (ED‐A FN) and the antifibrotic proteins tumor necrosis factor‐α (TNF‐α) and γ‐interferon (IFN‐γ).—Leask, A., Abraham, D. J. TGF‐β signaling and the fibrotic response. FASEB J. 18, 816–827 (2004)
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“TGF-β is the critical mediator of pathological fibrosis after myocardial injury [64].”
From Cardiovascular disease models: A game changing paradigm in drug discovery and screening (2019) · cites this paper as [64]
In the citing paper
“TNFα also suppresses the TGFβ stimulation of ECM production.62”
From The Innate Immune System in Acute and Chronic Wounds (2016) · cites this paper as [62]
Citations
Cites
1 retracted
RETRACTED: Deficient Smad7 expression: A putative molecular defect in scleroderma
Dong, C., Zhu, S., Wang, T., Yoon, W., Li, Z., Alvarez, R. J., ten Dijke, P., White, B., Wigley, F. M., & Goldschmidt-Clermont, P. J. (2002) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.062010399 · Cited by 244 · cited 1×
“Although one report showed decreased levels of the inhibitory Smad7 in scleroderma fibroblasts (94), two other studies showed no difference in Smad7 levels between normal and scleroderma fibroblasts (65, 91); thus, Smad7 deficiency does not seem to be a general feature of scleroderma fibroblasts.”
ResultRetractedMassagué, J. (1998) · Annual Review of Biochemistry · doi:10.1146/annurev.biochem.67.1.753 · Cited by 7,556 · cited 4×
“The TGF- superfamily includes nearly 30 proteins in mammals including TGF- s, activins and inhibins, nodal, myostatin, bone morphogenetic proteins (BMPs), growth/differentiation factors (GDFs), and anti-Müllerian hormone (AMH, also called Müllerianinhibiting substance or MIS) (15, 16).”
BackgroundInfluentialDarnell, J. E., Kerr, L. M., & Stark, G. R. (1994) · Science · doi:10.1126/science.8197455 · Cited by 6,080 · cited 2×
“Transcriptional responses induced by IFN- in most cells are mediated through the Jak-Stat pathway (146).”
BackgroundCELLULAR RESPONSES TO INTERFERON-γ
Boehm, U., Klamp, T., Groot, M., & Howard, J. C. (1997) · Annual Review of Immunology · doi:10.1146/annurev.immunol.15.1.749 · Cited by 2,890 · cited 1×
“IFN- , a pleiotropic cytokine produced by T cells and NK cells, plays fundamental roles in innate and acquired immune responses (145).”
BackgroundYu, Q., & Stamenkovic, I. (2000) · PubMed Central · Cited by 2,203
Munger, J. S., Huang, X., Kawakatsu, H., Griffiths, M. J. D., Dalton, S. L., Wu, J., Pittet, J.-F., Kaminski, N., Garat, C., Matthay, M. A., et al. (1999) · Cell · doi:10.1016/s0092-8674(00)80545-0 · Cited by 2,076 · cited 1×
“TSP-1 null mice demonstrate a partial phenotypic overlap with TGF- 1 null animals (30), and integrin 6 / are highly resistant to lung fibrosis induced by the profibrotic drug bleomycin (31).”
BackgroundIdentification of Smad7, a TGFβ-inducible antagonist of TGF-β signalling
Nakao, A., Afrakhte, M., Morn, A., Nakayama, T., Christian, J. L., Heuchel, R., Itoh, S., Kawabata, M., Heldin, N.-E., Heldin, C.-H., et al. (1997) · Nature · doi:10.1038/39369 · Cited by 1,809
Yu, Q., & Stamenkovic, I. (2000) · Genes & Development · doi:10.1101/gad.14.2.163 · Cited by 1,754 · cited 1×
“For example, the plasmin proteases MMP-2 and -9, which promote matrix degradation (24), activate TGF- (25, 26).”
BackgroundThe myofibroblast in wound healing and fibrocontractive diseases
Gabbiani, G. (2003) · The Journal of Pathology · doi:10.1002/path.1427 · Cited by 1,630 · cited 5×
“observed in lesions of fibrotic disease (2).”
BackgroundInfluentialMaking sense of latent TGFβ activation
Annes, J. P., Munger, J. S., & Rifkin, D. B. (2003) · Journal of Cell Science · doi:10.1242/jcs.00229 · Cited by 1,628
Research works printed but not linked: 3
- 10.1111/j.1523-1755.2002.kid567.x · doi:10.1111/j.1523-1755.2002.kid567.x · Paper page
- Schmid P., 1998, Enhanced expression oftransforming growth factor-beta type and type II receptors in wound granulation tissue and hyper trophic scar, Am. J. Pathol., 152, 485
- 10.1111/j.1523-1755.1998.00820.x · doi:10.1111/j.1523-1755.1998.00820.x · Paper page
Cited by
Items 801–900 of 1,008
Burke, J. P., Watson, R. W. G., Murphy, M., Docherty, N. G., Coffey, J. C., & O’Connell, P. R. (2009) · British journal of surgery · doi:10.1002/bjs.6577 · Cited by 47
Fibroblast adhesion results in the induction of a matrix remodeling gene expression program
KENNEDY, L., Shiwen, X., Carter, D., Abraham, D., & Leask, A. (2008) · Matrix Biology · doi:10.1016/j.matbio.2008.01.004 · Cited by 48
Self-citationWang, W., Vootukuri, S., Meyer, A., Ahamed, J., & Coller, B. S. (2014) · Arteriosclerosis Thrombosis and Vascular Biology · doi:10.1161/atvbaha.114.303852 · Cited by 51
Distinct PKA and Epac compartmentalization in airway function and plasticity
Dekkers, B. G. J., Racké, K., & Schmidt, M. (2012) · Pharmacology & Therapeutics · doi:10.1016/j.pharmthera.2012.10.006 · Cited by 49
Zhang, Y., Wang, Y., Yang, K., Tian, L., Fu, X., Wang, Y., Sun, Y., Jiang, Q., Lu, W., & Wang, J. (2014) · PLoS ONE · doi:10.1371/journal.pone.0112695 · Cited by 47
The response of tenocytes to commercial scaffolds used for rotator cuff repair
Smith, R., Carr, A. J., Dakin, S. G., Snelling, S. J. B., Yapp, C., & Hakimi, O. (2016) · European Cells and Materials · doi:10.22203/ecm.v031a08 · Cited by 50
Ji, Y., Zhang, A., Chen, X., Che, X., Zhou, K., & Wang, Z. (2016) · Acta Pharmaceutica Sinica B · doi:10.1016/j.apsb.2016.01.009 · Cited by 49
TIEG1 Represses Smad7-Mediated Activation of TGF-β1/Smad Signaling in Keloid Pathogenesis
Hu, Z., Shi, F., Liu, P., Zhang, J., Guo, D. Y., Cao, X., Chen, C., Qu, S., Zhu, J., & Tang, B. (2017) · Journal of Investigative Dermatology · doi:10.1016/j.jid.2016.12.019 · Cited by 49
Expansion of CD26 positive fibroblast population promotes keloid progression
Yu, X., Wang, X., Zhu, M. J., Qu, M., Bogari, M., Lin, L., Aung, Z. M., Chen, W., Chen, X., Chai, G., et al. (2017) · Experimental Cell Research · doi:10.1016/j.yexcr.2017.04.021 · Cited by 48
Development of a topical mupirocin spray for antibacterial and wound-healing applications
Sritharadol, R., Nakpheng, T., Heng, P. W. S., & Srichana, T. (2017) · Drug Development and Industrial Pharmacy · doi:10.1080/03639045.2017.1339077 · Cited by 47
Unraveling the role of genetics in the pathogenesis of diabetic retinopathy
Sharma, A. K., del Valle, M. L., Beveridge, C., Liu, Y., & Sharma, S. (2019) · Eye · doi:10.1038/s41433-019-0337-y · Cited by 47
Liang, C., Yen, Y., Hung, L.-Y., Wang, S., Pu, C., Chien, H., Tsai, J., Lee, C., Yen, F., & Chen, Y. (2013) · Biochemical Pharmacology · doi:10.1016/j.bcp.2013.02.038 · Cited by 53
Cayón, A., Crespo, J., Mayorga, M., Guerra, A., & Pons‐Romero, F. (2006) · Liver International · doi:10.1111/j.1478-3231.2006.01337.x · Cited by 45
Chen, L., Wang, T., Wang, X., Sun, B., Li, J.-Q., Liu, D., Zhang, S., Liu, L., Xu, D., Chen, Y., et al. (2009) · Respiratory Research · doi:10.1186/1465-9921-10-55 · Cited by 48
“Moreover, TGFb, especially the isoform TGFb1, is a key fibrotic stimulator in pulmonary fibrosis [ 15 ].”
BackgroundChen, Y., Leask, A., Abraham, D., Kennedy, L., Shiwen, X., Denton, C. P., Black, C. M., Verjee, L. S., & Eastwood, M. (2011) · Fibrogenesis & Tissue Repair · doi:10.1186/1755-1536-4-9 · Cited by 47
Self-citationChen, Y., He, Z., Su, M., Li, L., Yang, H., & Zhang, X. (2013) · Journal of International Medical Research · doi:10.1177/0300060513480926 · Cited by 53
Activation of Transforming Growth Factor-β by the Integrin αvβ8 Delays Epithelial Wound Closure
Neurohr, C., Nishimura, S. L., & Sheppard, D. (2006) · American Journal of Respiratory Cell and Molecular Biology · doi:10.1165/rcmb.2006-0013oc · Cited by 44
Late small bowel toxicity after adjuvant treatment for rectal cancer
Gückenberger, M., & Flentje, M. P. (2005) · International Journal of Colorectal Disease · doi:10.1007/s00384-005-0765-y · Cited by 46
“The pro-fibrotic cytokine TGF-beta seems to be a key player in fibroproliferative processes [ 20 ].”
BackgroundRapamycin induces the TGFβ1/Smad signaling cascade in renal mesangial cells upstream of mTOR
Osman, B., Doller, A., Akool, E., Holdener, M., Hintermann, E., Pfeilschifter, J. M., & Eberhardt, W. (2009) · Cellular Signalling · doi:10.1016/j.cellsig.2009.07.016 · Cited by 49
New molecular medicine-based scar management strategies
Arno, A. I., Gauglitz, G. G., Barret, J. P., & Jeschke, M. G. (2014) · Burns · doi:10.1016/j.burns.2013.11.010 · Cited by 47
“on-turning/off-turning mechanisms and crosstalks [5,13,17].”
BackgroundAraújo, K. P. C., Bonuccelli, G., Duarte, C. N., Gaiad, T. P., Moreira, D., Feder, D., Belizário, J. E., Miglino, M. A., Lisanti, M. P., & Ambrósio, C. E. (2013) · PLoS ONE · doi:10.1371/journal.pone.0061367 · Cited by 52
“The activation of NFkB and the acute activation of TGF-b1 in human dystrophin-deficient muscle tissue cause the failure of metabolic pathways later in the disease and appear to be associated with symptoms and muscle wasting in DMD [21].”
BackgroundInfluentialXu, Z., Ramachandran, S., Gunasekaran, M., Zhou, F., Trulock, E. P., Kreisel, D., Hachem, R. R., & Mohanakumar, T. (2015) · The Journal of Heart and Lung Transplantation · doi:10.1016/j.healun.2015.03.021 · Cited by 51
Fox, J. L., Dews, M., Minn, A. J., & Thomas‐Tikhonenko, A. (2012) · RNA · doi:10.1261/rna.036467.112 · Cited by 47
“…previous data from our laboratory and collaborators have also linked miR17∼92 to the TGFβ pathway (Dews et al. 2010; Mestdagh et al. 2010), an established transcriptional activator of CTGF expression (Grotendorst 1997; Abreu et al. 2002; Leask and Abraham 2004; Perbal 2004; Baxter and Twigg 2009).”
BackgroundMatsuzaki, S., Darcha, C., Pouly, J.-L., & Canis, M. (2017) · Scientific Reports · doi:10.1038/srep44616 · Cited by 42
Sudden cardiac death: focus on the genetics of channelopathies and cardiomyopathies
Magi, S., Lariccia, V., Maiolino, M., Amoroso, S., & Gratteri, S. (2017) · Journal of Biomedical Science · doi:10.1186/s12929-017-0364-6 · Cited by 51
Dong, H., Luo, L., Zou, M., Huang, C., Wan, X., Hu, Y., Le, Y., Zhao, H., Li, W., Zou, F., et al. (2017) · American Journal of Physiology-Lung Cellular and Molecular Physiology · doi:10.1152/ajplung.00489.2016 · Cited by 42
TGF-β1 in Vascular Wall Pathology: Unraveling Chronic Venous Insufficiency Pathophysiology
Serralheiro, P. A., Soares, A. M., Almeida, C. C., & Verde, I. (2017) · International Journal of Molecular Sciences · doi:10.3390/ijms18122534 · Cited by 52
Huard, J., Bolia, I. K., Briggs, K. K., Utsunomiya, H., Lowe, W. R., & Philippon, M. J. (2018) · Orthopedics · doi:10.3928/01477447-20180806-05 · Cited by 47
Hong, L., Li, F., Tang, C., Li, L., Sun, L., Li, X., & Zhu, L. (2020) · Cell Death and Disease · doi:10.1038/s41419-020-02818-x · Cited by 47
TGF-β1 enhances contractility in engineered skeletal muscle
Weist, M. R., Wellington, M. S., Bermudez, J. E., Kostrominova, T. Y., Mendias, C. L., Arruda, E. M., & Larkin, L. M. (2012) · Journal of Tissue Engineering and Regenerative Medicine · doi:10.1002/term.551 · Cited by 46
“However, excessive exposure to TGF-b1 can induce fibrosis in skeletal muscle (Leask and Abraham, 2004), which is likely due to overproduction of ECM (Stauber et al., 1996; Duncan et al., 1999).”
BackgroundSawaki, D., Hou, L., Tomida, S., Sun, J., Zhan, H., Aizawa, K., Son, B., Kariya, T., Takimoto, E., Otsu, K., et al. (2015) · Cardiovascular Research · doi:10.1093/cvr/cvv155 · Cited by 49
Blockade of IP-10/CXCR3 Promotes Progressive Renal Fibrosis
Nakaya, I., Wada, T., Furuichi, K., Sakai, N., Kitagawa, K., Yokoyama, H., Ishida, Y., Kondo, T., Sugaya, T., Kawachi, H., et al. (2007) · Nephron Experimental Nephrology · doi:10.1159/000106505 · Cited by 46
Mezzano, V., Cabrera, D., Vial, C., & Brandan, E. (2007) · Journal of Cell Communication and Signaling · doi:10.1007/s12079-008-0018-2 · Cited by 51
Chen, Y., Leask, A., Abraham, D., Pala, D., Shiwen, X., Khan, K., Liu, S., Carter, D. E., Wilcox‐Adelman, S. A., Goetinck, P. F., et al. (2008) · Arthritis & Rheumatism · doi:10.1002/art.23146 · Cited by 49
Self-citationInhibition of NF-κB by ACT001 reduces fibroblast activity in idiopathic pulmonary fibrosis
Jaffar, J., Glaspole, I., Symons, K., & Westall, G. (2021) · Biomedicine & Pharmacotherapy · doi:10.1016/j.biopha.2021.111471 · Cited by 45
Psoriasis and extra domain A fibronectin loops
McFadden, J. P., Baker, B. S., Powles, A. V., & Fry, L. (2010) · British Journal of Dermatology · doi:10.1111/j.1365-2133.2010.09737.x · Cited by 45
Gürer, B., Kahveci, R., Gökçe, E. C., Özevren, H., Türkoğlu, E., & Gökçe, A. (2014) · The Spine Journal · doi:10.1016/j.spinee.2014.10.018 · Cited by 45
Anthony, B. J., James, K. R., Gobert, G. N., Ramm, G. A., & McManus, D. P. (2013) · PLoS ONE · doi:10.1371/journal.pone.0068479 · Cited by 50
Langhe, E. D., Cailotto, F., Vooght, V. D., Aznar-Lopez, C., Vanoirbeek, J., Luyten, F. P., & Lories, R. J. U. (2015) · Respiratory Research · doi:10.1186/s12931-015-0202-x · Cited by 48
“Fibrosis is characterized by excessive production, deposition, and contraction of extracellular matrix and is considered an end-stage process responsible for organ dysfunction and potential organ failure [1].”
BackgroundSood, R. F., Gibran, N. S., Arnoldo, B. D., Gamelli, R. L., Herndon, D. N., & Tompkins, R. G. (2015) · The Journal of Trauma: Injury, Infection, and Critical Care · doi:10.1097/ta.0000000000000905 · Cited by 47
Huan, C., Yang, T., Liang, J., Xie, T., Cheng, L., Liu, N., Kurkciyan, A., Mena, J. M., Wang, C., Dai, H., et al. (2015) · Scientific Reports · doi:10.1038/srep14910 · Cited by 48
Albadrani, G. M., BinMowyna, M. N., Bin-Jumah, M. N., El–Akabawy, G., Aldera, H., & AL-Farga, A. M. (2021) · Saudi Journal of Biological Sciences · doi:10.1016/j.sjbs.2021.02.007 · Cited by 45
“…inhibiting proteases (i.e. Matrix metallopeptidases (MMPs) and collagenases), upregulating MMPs protease inhibitors, and stimulating the release of the connective tissue growth factor (CTGF) (Leask and Abraham, 2004; Mauviel, 2005; Schneiders et al., 2005; Liu et al., 2016; Ma et al., 2018).”
BackgroundInflammatory bowel disease–associated intestinal fibrosis
Park, J. M., Kim, J., Lee, Y. J., Bae, S. U., & Lee, H. W. (2023) · Journal of Pathology and Translational Medicine · doi:10.4132/jptm.2022.11.02 · Cited by 45
Modulation of Fibrosis in Systemic Sclerosis by Nitric Oxide and Antioxidants
Dooley, A., Bruckdorfer, K. R., & Abraham, D. (2011) · Cardiology Research and Practice · doi:10.1155/2012/521958 · Cited by 46
“, NFκB, AP-1, SP-1) [88] which are key signalling pathways of fibroblast proliferation and collagen gene expression [6, 8, 25, 89, 90] (Figure 1).”
BackgroundSelf-citationQiu, C., Zhao, Z., Xu, C., Yuan, R., Ha, Y., Tu, Q., Zhang, H., Mu, Z., Xin, Q., Tian, Y., et al. (2024) · Journal of Nanobiotechnology · doi:10.1186/s12951-024-02721-z · Cited by 45
Narayanan, S., Kalayarasan, S., Manikandan, R., Arumugam, M., & Sudhandiran, G. (2015) · Clinical and Experimental Pharmacology and Physiology · doi:10.1111/1440-1681.12428 · Cited by 51
Connective tissue growth factor (CCN2) in blood vessels
Ponticos, M. (2013) · Vascular Pharmacology · doi:10.1016/j.vph.2013.01.004 · Cited by 48
McFadden, J. P., Basketter, D. A., Dearman, R. J., & Kimber, I. (2011) · Clinics in Dermatology · doi:10.1016/j.clindermatol.2010.11.003 · Cited by 44
Deng, J., Shi, Y., Gao, Z., Zhang, W., Wu, X., Cao, W., & Liu, W. (2017) · Tissue Engineering Part A · doi:10.1089/ten.tea.2016.0550 · Cited by 45
Medeiros, N. I., Gomes, J. D. A. S., & Corrêa‐Oliveira, R. (2017) · Parasite Immunology · doi:10.1111/pim.12446 · Cited by 55
Shu, D. Y., Hutcheon, A. E. K., Zieske, J. D., & Guo, X. Q. (2019) · Scientific Reports · doi:10.1038/s41598-019-42969-2 · Cited by 46
Dynamic changes of the extracellular matrix during corneal wound healing
Lorenzo-Martín, E., Gallego‐Muñoz, P., Mar, S., Fernández, I., Cidad, P., & Martínez‐García, C. (2019) · Experimental Eye Research · doi:10.1016/j.exer.2019.107704 · Cited by 46
“The recovery from these types of damage is a complex process that requires the replacement of injured cells and tissues (Leask and Abraham, 2004).”
BackgroundTian, J., Pecaut, M. J., Slater, J. M., & Gridley, D. S. (2010) · Journal of Applied Physiology · doi:10.1152/japplphysiol.00730.2009 · Cited by 43
Iguchi, N., Hou, A. H., Koul, H. K., & Wilcox, D. T. (2014) · The Journal of Urology · doi:10.1016/j.juro.2014.03.037 · Cited by 44
Rama, A., Matsushita, T., Charolidi, N., ROTHERY, S. M., Dupont, E., & Severs, N. J. (2006) · European Journal of Cell Biology · doi:10.1016/j.ejcb.2005.11.007 · Cited by 47
Crean, J. K. G., Furlong, F. M., Mitchell, D., McArdle, E., Godson, C., & Martin, F. (2006) · The FASEB Journal · doi:10.1096/fj.05-5010fje · Cited by 44
Transforming growth factor-β1 reduces apoptosis via autophagy activation in hepatic stellate cells
Fu, M.-Y., HE, Y.-J., Lv, X., Liu, Z., Shen, Y., Ye, G.-R., Deng, Y.-M., & Shu, J.-C. (2014) · Molecular Medicine Reports · doi:10.3892/mmr.2014.2383 · Cited by 45
Allan, G. J., Beattie, J., & Flint, D. J. (2008) · Journal of Endocrinology · doi:10.1677/joe-08-0269 · Cited by 56
“TGFB1 has been shown to stimulate fibroblast proliferation and the production of ECM components in vitro, making it a prime candidate as a causative factor (Takehara 2003, Leask & Abraham 2004).”
Delayed Wound Repair in Sepsis Is Associated with Reduced Local Pro-Inflammatory Cytokine Expression
Sommer, K., Sander, A. L., Albig, M., Weber, R., Henrich, D. M., Frank, J. M., Marzi, İ., & Jakob, H. (2013) · PLoS ONE · doi:10.1371/journal.pone.0073992 · Cited by 50
Kuo, H., Onouchi, Y., Hsu, Y.-W., Chen, W.-C., Huang, J.-D., Huang, Y., Yang, Y., Chao, M., Yu, H., Juan, Y., et al. (2011) · Journal of Human Genetics · doi:10.1038/jhg.2011.113 · Cited by 43
Matsuzaki, S., Botchorishvili, R., Pouly, J. L., & Canis, M. J. (2014) · Molecular and Cellular Therapies · doi:10.1186/s40591-014-0036-9 · Cited by 49
“Fibroblast migration, proliferation, and collagen contraction are main hallmarks of fibrogenesis [51].”
BackgroundMatsuzaki, S., Canis, M. J., Pouly, J. L., & Darcha, C. (2016) · Human Reproduction · doi:10.1093/humrep/dev333 · Cited by 48
“Furthermore, transforming growth factor (TGF)-b1 is the most potent key mediator of fibrosis (Leask and Abraham, 2004; Biernacka et al., 2007).”
BackgroundMiRNA-21 promotes fibrosis in orbital fibroblasts from thyroid-associated ophthalmopathy.
Tong, B., Xiao, M., Zeng, J., & Xiong, W. (2015) · PubMed Central · Cited by 47
Izzo, R., Bevivino, G., Simone, V. D., Sedda, S., Monteleone, I., Marafini, I., Giovangiulio, M. D., Rizzo, A., Franzè, E., Colantoni, A., et al. (2018) · Inflammatory Bowel Diseases · doi:10.1093/ibd/izy062 · Cited by 45
The role of NOX4 in pulmonary diseases
Li, Z., Xu, S., Feng, Y., Cheng, Y., Xiong, J., Zhou, Y., & Guan, C. (2020) · Journal of Cellular Physiology · doi:10.1002/jcp.30005 · Cited by 45
“In pulmonary fibrosis, TGF‐β promotes the recruitment and differentiation of fibroblasts, synthesis of structural matrix proteins (Leask & Abraham, 2004), and epithelial‐mesenchymal transition (EMT; Kovacic, Mercader, Torres, Boehm, & Fuster, 2012).”
BackgroundTransforming Growth Factor-β1 Induced Urethral Fibrosis in a Rat Model
Sangkum, P., Gökçe, A., Tan, R., Bouljihad, M. T., Kim, H., Mandava, S. H., Saleem, S. N., Lasker, G. F., Yafi, F. A., Elmageed, Z. Y. A., et al. (2015) · The Journal of Urology · doi:10.1016/j.juro.2015.02.014 · Cited by 43
Zheng, Z. S., Lee, K. S., Zhang, X., Nguyen, C., Hsu, C., Wang, J. Z., Rackohn, T. M., Enjamuri, D. R., Murphy, M. C., Ting, K., et al. (2014) · PLoS ONE · doi:10.1371/journal.pone.0090817 · Cited by 43
Elmarakby, A. A., Abdelsayed, R. A., Liu, J. Y., & Mozaffari, M. S. (2010) · The EPMA Journal · doi:10.1007/s13167-010-0004-7 · Cited by 48
“CCN2, formerly named connective tissue growth factor (CTGF), is now known to be a major downstream effector of TGF-β signaling [131].”
BackgroundHalofuginone inhibits collagen deposition in fibrous capsules around implants.
Olbrich, K. C., Meade, R. A., Bruno, W., Heller, L., Klitzman, B. M., & Levin, L. S. (2005) · PubMed · Cited by 43
Chien, L.-H., Deng, J., Jiang, W., Chou, Y.-N., Lin, J., & Huang, G. (2023) · Biomedicine & Pharmacotherapy · doi:10.1016/j.biopha.2023.115080 · Cited by 47
Nam, Y. R., Won, S. B., Chung, Y.-S., Kwak, C. S., & Kwon, Y. H. (2015) · Nutrition Research and Practice · doi:10.4162/nrp.2015.9.3.235 · Cited by 44
“TGF-β is an important regulator of fibrosis by enhancement of alpha smooth muscle actin (α-SMA) and COL1A1 [33].”
BackgroundEnhanced Bioactive Myocardial Transforming Growth Factor-β in Advanced Human Heart Failure
Khan, S. A., Joyce, J., Margulies, K. B., & Tsuda, T. (2014) · Circulation Journal · doi:10.1253/circj.cj-14-0511 · Cited by 42
Cabrera, D., Gutiérrez, J., Cabello‐Verrugio, C., Morales, M. G., Mezzano, S. A., Fadić, R., Casar, J. C., Hancke, J. L., & Brandan, E. (2014) · Skeletal Muscle · doi:10.1186/2044-5040-4-6 · Cited by 42
Liu, X., Hong, Q., Wang, Z., Yu, Y., Zou, X., & Xu, L. (2015) · Experimental Biology and Medicine · doi:10.1177/1535370215605586 · Cited by 42
Mathematical modeling of liver fibrosis
Friedman, A., & Hao, W. (2016) · Mathematical Biosciences & Engineering · doi:10.3934/mbe.2017010 · Cited by 47
Carino, A., Biagioli, M., Marchianò, S., Scarpelli, P., Zampella, A., Limongelli, V., & Fiorucci, S. (2018) · Pharmacological Research · doi:10.1016/j.phrs.2018.02.033 · Cited by 44
“Moreover, TGFβ activates different mitogen-activated protein kinase (MAPK) signaling pathways, among which extracellular signalregulated kinase (ERK, also known as MAPK1), p38 and c‐jun N‐terminal kinase (JNK), to promote HSC activation, and that represent an important trigger of HSCs migration and contraction [14].”
BackgroundHong, W., Zhang, G., Lu, H., Guo, Y., Zheng, S., Zhu, H., Xiao, Y., Papa, A. P. D., Wu, C., Sun, L., et al. (2019) · Cell Communication and Signaling · doi:10.1186/s12964-019-0455-y · Cited by 44
LncRNA GAS5 attenuates fibroblast activation through inhibiting Smad3 signaling
Tang, R., Wang, Y.-C., Mei, X., Shi, N., Sun, C., Ran, R., Zhang, G., Li, W., Staveley-O’Carroll, K. F., Li, G., et al. (2020) · American Journal of Physiology-Cell Physiology · doi:10.1152/ajpcell.00059.2020 · Cited by 45
Cui, Y., Osorio, J. C., Risquez, C. F., Wang, H., Shi, Y., Gochuico, B. R., Morse, D., Rosas, I. O., & El‐Chemaly, S. (2014) · Molecular Medicine · doi:10.2119/molmed.2013.00123 · Cited by 42
Resveratrol attenuates radiation‐induced salivary gland dysfunction in mice
Xu, L., Yang, X., Cai, J., Ma, J.-X., Cheng, H., Zhao, K., Yang, L., Cao, Y., Qin, Q., Zhang, C., et al. (2013) · The Laryngoscope · doi:10.1002/lary.24276 · Cited by 42
Wolff, R. A., Ryomoto, M., Stark, V. E., Malinowski, R. L., Tomas, J. J., Stinauer, M. A., Hullett, D. A., & Hoch, J. R. (2005) · Journal of Vascular Surgery · doi:10.1016/j.jvs.2004.12.037 · Cited by 42
Scleroderma: from pathophysiology to novel therapeutic approaches
Hunzelmann, N., & Krieg, T. M. (2010) · Experimental Dermatology · doi:10.1111/j.1600-0625.2010.01082.x · Cited by 51
Greco, K. V., Francis, L., Somasundaram, M., Greco, G. N., English, N. R., Roether, J. A., Boccaccini, A. R., Sibbons, P. D., & Ansari, T. (2015) · Journal of Biomaterials Applications · doi:10.1177/0885328215578638 · Cited by 46
“it stimulates these cells by autocrine and paracrine effects to proliferate and also to produce ECM components.(40) MSCs synthesise and release TGF-b1 that not only increases a1-procollagen production(41) but have also been demonstrated to increase other ECM proteins, such as hyaluronan when in contact with scaffolds.”
BackgroundLi, A. G., Quinn, M. J., Siddiqui, Y., Wood, M. D., Federiuk, I. F., Duman, H. M., & Ward, W. K. (2007) · Journal of Biomedical Materials Research Part A · doi:10.1002/jbm.a.31168 · Cited by 42
Watanabe-Takano, H., Takano, K., Hatano, M., Tokuhisa, T., & Endo, T. (2015) · PLOS ONE · doi:10.1371/journal.pone.0127888 · Cited by 42
“TGF-β 1-induced EMT in AEC2s is generally considered to be responsible for pulmonary fibrosis [9 – 13].”
Biomaterial-based platforms for modulating immune components against cancer and cancer stem cells
Desai, N., Hasan, U., Jeyashree, K., Mani, R., Chauhan, M. K., Basu, S. M., & Giri, J. (2023) · Acta Biomaterialia · doi:10.1016/j.actbio.2023.03.004 · Cited by 43
Sun, H., Ren, C., Lee, D. H., Wang, W., Guo, X., Hao, Y., Wang, X., Zhang, H., Xiao, W.-Q., Li, N., et al. (2023) · Cellular & Molecular Biology Letters · doi:10.1186/s11658-023-00460-x · Cited by 42
Jiang, Y., Wang, C., Li, Y., Wang, X., An, J.-D., Wang, Y., & Wang, X. (2014) · Journal of Ethnopharmacology · doi:10.1016/j.jep.2014.10.028 · Cited by 41
Role of transcription factor AP-1 in integration of cell signaling systems
Turpaev, K. T. (2006) · Molecular Biology · doi:10.1134/s0026893306060033 · Cited by 43
“The ATF/CREB family includes six main subgroups: CREB (also including CREM and ATF-1), ATF-2 (also including CREBP-1), ATF-3, ATF-4, ATF-6, and B-ATF.”
BackgroundInfluentialSphingosine-1-Phosphate Mediates Fibrosis in Orbital Fibroblasts in Graves' Orbitopathy
Ko, J., Chae, M. K., Lee, J. H., Lee, E. J., & Yoon, J. S. (2017) · Investigative Ophthalmology & Visual Science · doi:10.1167/iovs.16-20684 · Cited by 41
Park, S.-J., & Im, D. (2018) · Biomolecules & Therapeutics · doi:10.4062/biomolther.2018.131 · Cited by 41
“At the cellular level, a seminal step involves the accumulation/ activation of fibroblasts and myofibroblasts in the lung, with the subsequent release of pro-fibrotic factors and extracellular matrix proteins, including proteoglycans and collagens (Leask and Abraham, 2004).”
BackgroundDNA methylation regulates α‐smooth muscle actin expression during cardiac fibroblast differentiation
He, Y., Ling, S., Sun, Y., Sheng, Z., Chen, Z., Pan, X., & Ma, G. (2018) · Journal of Cellular Physiology · doi:10.1002/jcp.27471 · Cited by 46
“The Smad signaling pathway is considered the main intracellular signal transduction pathway (Leask & Abraham, 2004).”
BackgroundThe Role of Airway Myofibroblasts in Asthma
Jendzjowsky, N. G., & Kelly, M. M. (2019) · CHEST Journal · doi:10.1016/j.chest.2019.08.1917 · Cited by 46
“Point of no return” in unilateral renal ischemia reperfusion injury in mice
Holderied, A., Kraft, F., Marschner, J. A., Weidenbusch, M. J., & Anders, H. (2020) · Journal of Biomedical Science · doi:10.1186/s12929-020-0623-9 · Cited by 45
Krishna Murthy, P., Sivashanmugam, K., Kandasamy, M., Rajasekaran, S., & Ravikumar, V. (2020) · Life Sciences · doi:10.1016/j.lfs.2020.118883 · Cited by 56
Weidinger, A., Poženel, L., Wolbank, S., & Banerjee, A. (2021) · Frontiers in Bioengineering and Biotechnology · doi:10.3389/fbioe.2020.613804 · Cited by 47
“However, its potential pro-fibrotic function (Leask and Abraham, 2004; Walton et al., 2017) should be taken into account if the prevention of scar tissue formation is important.”
BackgroundBurke, J. P., Ferrante, M., Dejaegher, K., Watson, R. W. G., Docherty, N. G., Hertogh, G. D., Vermeire, S., Rutgeerts, P., D’Hoore, A. J. L., PENNINCKX, F. M., et al. (2008) · Inflammatory Bowel Diseases · doi:10.1002/ibd.20482 · Cited by 41
Dawes, L. J., Eldred, J. A., Anderson, I. K., Sleeman, M. A., Reddan, J. R., Duncan, G., & Wormstone, I. M. (2008) · Investigative Ophthalmology & Visual Science · doi:10.1167/iovs.07-0586 · Cited by 49
Amnion Epithelial Cells as a Candidate Therapy for Acute and Chronic Lung Injury
Hodges, R. J., Lim, R., Jenkin, G., & Wallace, E. M. (2012) · Stem Cells International · doi:10.1155/2012/709763 · Cited by 43
“Since TGF-β signalling plays a central role in pulmonary fibrosis [50] the ability of hAECs to decrease TGF-β signalling and prevent fibroblast activation is likely to be an important effector mechanism in their reparative properties.”
BackgroundPapaconstantinou, I. G., Zeglinas, C., Gazouli, M., Nastos, C., Yiallourou, A., Papalois, A. E., & Tzathas, C. (2014) · Journal of Gastrointestinal Surgery · doi:10.1007/s11605-014-2487-3 · Cited by 41
Metadata
- Authors
- Leask, A., & Abraham, D. J.
- Affiliations
- The Royal Free Hospital (GB)
- Venue
- The FASEB Journal
- Publisher
- Wiley
- Published
- 2004-05
- Volume
- 18
- Issue
- 7
- Pages
- 816-827
- ISSN
- 0892-6638 (ISSN-L)
- 1530-6860
- OpenAlex
- W2122808924
- Cited by
- 2,319
- References
- 153
- Citations by year
- 2026: 53 · 2025: 53 · 2024: 63 · 2023: 79 · 2022: 75 · 2021: 103 · 2020: 99 · 2019: 113 · 2018: 145 · 2017: 174 · 2016: 163 · 2015: 179 · 2014: 141 · 2013: 134 · 2012: 115
- FWCI
- 6.39
- Type
- journal article
- Language
- en
- Open access
- closed
- Locations
- The FASEB Journal (publishedVersion)
- PubMed (publishedVersion)
- UCL Discovery (University College London) (submittedVersion)
- Funders
- Scleroderma Foundation
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Connective Tissue Growth Factor Research
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › TGF-β signaling in diseases
- Health Sciences › Medicine › Cardiology and Cardiovascular Medicine › Cardiac Fibrosis and Remodeling
- Keywords
- TGF-beta signaling, fibrosis, fibrogenesis, extracellular matrix deposition, connective tissue growth factor, ED-A fibronectin, TNF-α, interferon-gamma
- MeSH terms
- Animals, DNA-Binding Proteins, Fibronectins, Fibrosis, Gene Expression Regulation, Humans, Interferon-gamma, Tumor Necrosis Factor-alpha, Wound Healing, Signal Transduction, Trans-Activators, Transforming Growth Factor beta, Extracellular Matrix Proteins, Immediate-Early Proteins, Receptors, Transforming Growth Factor beta, MAP Kinase Signaling System, Intercellular Signaling Peptides and Proteins, Smad3 Protein, Smad4 Protein, Connective Tissue Growth Factor
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.